These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7201539)

  • 1. [Studies on cortical tissue plasminogen activator in renal disease. Part I: Studies in the glomerulonephritis (author's transl)].
    Morozumi K
    Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):153-66. PubMed ID: 7201539
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].
    Shibata K; Dohi K; Fujii Y; Ishikawa H
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Kidneys as an effector in the regulation of blood clotting].
    Sokratov NV; Skipetrov VP
    Usp Fiziol Nauk; 1981; 12(1):80-96. PubMed ID: 7013321
    [No Abstract]   [Full Text] [Related]  

  • 4. [Releasing of plasminogen-activator from the kidney to the blood (author's transl)].
    Nakata A; Hagita M; Okamoto U
    Nihon Seirigaku Zasshi; 1978 Nov; 40(11):419-26. PubMed ID: 155161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrinolytic activity of the renal glomerulus. Preliminary results of a histochemical study of plasminogen activity in 44 renal biopsies].
    Arrigo G; Baroni M; Benuzzi S; Bellini A; Chiesa I; Colasanti G; D'Amico G
    Minerva Nefrol; 1979; 26(4):459-62. PubMed ID: 161611
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the standardization of fibrinolysis tests. II. Clinical significance of determination of fibrinolytic factors and its interpretation (author's transl)].
    Egawa H; Hashimoto S; Suzuki K
    Rinsho Byori; 1979 Mar; 27(3):250-6. PubMed ID: 155750
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal cortical fibrinolytic activity in rabbits with chronic immune complex nephritis.
    Stark H; Miller K; Michael AF
    Isr J Med Sci; 1979 Jul; 15(7):610-2. PubMed ID: 158001
    [No Abstract]   [Full Text] [Related]  

  • 8. [The levels of antigens to plasminogen activators compared to their functional activity and inhibitor activity in patients with glomerulonephritis and amyloidosis].
    Bumblite ID; Poliantseva LR; Mukhin NA; Andreenko GV; Podorol'skaia LV; Liaginskiĭ AV; Varlamova NV
    Ter Arkh; 1992; 64(11):52-6. PubMed ID: 1293845
    [No Abstract]   [Full Text] [Related]  

  • 9. [Estimation of plasminogen tissue activator (author's transl)].
    Kohga S; Kanamori T; Kawai N
    Rinsho Byori; 1976 Apr; 24(4):321-4. PubMed ID: 945387
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies of tonsillitis from the aspect of protease-antiprotease. 2. Substances relation to fibrinolysis in tonsillar tissue of man (author's transl)].
    Kosugi T; Hamaya M
    Nihon Jibiinkoka Gakkai Kaiho; 1978 Apr; 81(4):349-57. PubMed ID: 660336
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tissue-plasminogen-activators of maternal and fetal rat lungs after application of betamethasone or bromhexine-metabolite VIII (author's transl)].
    Haas-Denk S; Krieglsteiner P; Wriedt-Lübbe I; Erhardt W; Münnich W; Blümel G
    Z Geburtshilfe Perinatol; 1976 Dec; 180(6):398-403. PubMed ID: 1014776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary fibrin/fibrinogen derivatives.
    Hedner U
    Thromb Diath Haemorrh; 1975 Dec; 34(3):693-708. PubMed ID: 54945
    [No Abstract]   [Full Text] [Related]  

  • 13. [Assay of fibrinolytic factors with plasminogen-free bovine fibrin-agar-plate and its clinical application. I. Some properties of plate and features for estimation of fibrinolytic factors (author's transl)].
    Abe T; Kazama M; Satoh A; Suzuki J; Yamamoto S
    Rinsho Ketsueki; 1975 Oct; 16(10):946-52. PubMed ID: 128644
    [No Abstract]   [Full Text] [Related]  

  • 14. [Examination of plasminogen-activators and plasmin-inhibitors in maternal and fetal rat-lung-tissue after administration of DL-carnitine-hydrochloride (author's transl)].
    Hückmann T; Blasini R; Haas S; Krieglsteiner P; Erhardt W; Wriedt-Lübbe I; Blümel G
    Z Geburtshilfe Perinatol; 1980 Feb; 184(1):54-9. PubMed ID: 6894511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thromboplastic, fibrinolytic and fibrinolysis-inhibitory activities of cultured human cancer cell lines (author's transl)].
    Naito S
    Fukuoka Igaku Zasshi; 1980 Apr; 71(4):207-20. PubMed ID: 7190116
    [No Abstract]   [Full Text] [Related]  

  • 16. [Index of fibrinolysis with new fibrin plate (author's transl)].
    Hishikawa Y; Sugie I
    Nihon Seirigaku Zasshi; 1977; 39(1):1-11. PubMed ID: 140239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The investigation on early diagnosis of the bladder tumor. II: A study on urinary cytology, urinary fibrin/fibrinogen degradation products, tissue fibrin deposition and tissue plasminogen activator activity in patients with bladder tumors (author's transl)].
    Tanahashi T
    Nihon Hinyokika Gakkai Zasshi; 1980 Sep; 71(9):1047-54. PubMed ID: 7193258
    [No Abstract]   [Full Text] [Related]  

  • 18. [The determination of antiactivator; especially inhibitors against the activator-induced fibrin clot lysis (author's transl)].
    Matsuda M; Yoshida N; Moroi M; Aoki N
    Rinsho Byori; 1976 Apr; 24(4):325-8. PubMed ID: 819683
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the fibrinolytic therapy in patients with various renal diseases. Clinical effects of urokinase (author's transl)].
    Takasaki H; Shibata M
    Nihon Jinzo Gakkai Shi; 1981 Sep; 23(9):1271-80. PubMed ID: 7035725
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasminogen activator and other trypsin-like proteases in the uterus wall and their participation on the tissue bleeding (author's transl)].
    Koutský J; Rybák M; Rybáková B
    Arch Gynakol; 1975 Dec; 220(1):11-8. PubMed ID: 1082328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.